期刊文献+

2型神经纤维瘤病NF2基因的突变分析 被引量:2

Mutation Analysis of NF2 Gene in a Chinese Neurofibromatosis lype 2 Kindred
下载PDF
导出
摘要 目的:探讨中国人常染色体显性遗传2型神经纤维瘤病的基因突变和分子诊断。方法:应用基因测序和限制性片段长度多态性分析技术,对1例经临床与病理诊断为2型神经纤维瘤病家系及100名无血缘关系正常人NF2基因编码区的17个外显子及其邻近内含子序列进行突变检测和分析。结果:家系中的所有患病者存在内含子13剪接供体位点(1446+1位)g→a的杂合性碱基点突变,而正常人和家系中未患病者无此突变,并排除了该位点基因多态性的可能。结论:该突变为国内外新发现的NF2基因内含子13剪接供体位点突变,突变导致的剪接异常影响了Merlin蛋白的生物学功能,使其失去对正常神经细胞生长的调控,导致2型神经纤维瘤病的发生。 Objective: To elucidate the molecular mechanism of neurofibromatosis type 2 (NF2) with autosomal dominant inheritance disease in a Chinese kindred. Methods: The entire coding region (from exon 1 through 17) of the NF2 gene was amplified using Polymerase chain reaction (PCR) and evaluated for mutations using direct sequencing of the PCR products. PCR-restriction fragment length posymorphism (PCR-RFLP) was performed to exclude the possibility of NF2 polymorphism in 100 normal control individuals. Results: The clinical and pathologic features including electron microscope examination established the diagnosis of NF2. A novel point mutation (1446 + 1 g→a) at the boundary of exon 13 and intron 13 was identified, which leads to an altered splice donor site and aberrant coding DNA sequence. Condusion:The de novo splice donor point mutation in intron 13 of NF2 gene which causes the production of a substantially truncated protein is related to the tumorigenesis of NF2.
出处 《中国临床医学》 北大核心 2005年第4期585-587,共3页 Chinese Journal of Clinical Medicine
关键词 2型神经纤维瘤病 基因突变 限制性片段长度多态性分析 Neurofibromatosis type 2, Gene mutation, Restriction fragment length polymorphism
  • 相关文献

参考文献7

  • 1Arai E, Ikeuchi T, Karasawa S, et al. Constitutional translocation t(4;22) (q12;q12. 2) associated with neurofibromatosis type 2[J]. Am J Med Genet, 1992, 44 :163-167.
  • 2Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2[J]. Nature, 1993, 363:515-521.
  • 3Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-,ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor[J]. Cell, 1993, 72:791-800.
  • 4MacCollin M, Mohney T, Trofatter J, et al. DNA diagnosis of neurofibrornatosis 2. Altered coding sequence of the merlin tumor suppressor in an extended pedigree[J]. JAMA, 1993, 270:2316-2320.
  • 5Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma[J]. Am J Pathol, 1995, 146:827-832.
  • 6王晓斌,刘国仰.有关内含子功能研究的新进展[J].中华医学遗传学杂志,2000,17(3):211-212. 被引量:33
  • 7Rubio MP, Correa KM, Ramesh V, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas[J]. Cancer Res, 1994, 54:45-47.

二级参考文献4

  • 1Kan J L,Genes Development,1999年,13期,462页
  • 2Kim C H,J Bio Chem,1999年,274卷,6507页
  • 3Kilpatrick M W,Mol Med Today,1998年,4期,376页
  • 4Pan T,Curr Opin Chem Biol,1997年,1卷,1期,17页

共引文献32

同被引文献18

  • 1罗世祺,石祥恩.双侧听神经瘤[J].中华神经外科杂志,1995,11(5):267-269. 被引量:10
  • 2卞留贯,孙青芳,沈建康,罗其中.多发神经纤维瘤病的临床和分子生物学研究[J].中华神经外科疾病研究杂志,2005,4(5):477-479. 被引量:10
  • 3BIAN Liu-guan,SUN Qing-fang,Tirakotai Wuttipong,ZHAO Wei-guo,SHEN Jian-kang,LUO Qi-zhong,Bertalanffy Helmut.Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells[J].Chinese Medical Journal,2005(18):1517-1524. 被引量:8
  • 4陈广理,陈沛,龚树生.神经纤维瘤病2型的研究[J].国际耳鼻咽喉头颈外科杂志,2006,30(5):321-324. 被引量:6
  • 5Ferner RE. Neurofi bromatosis 1 and neurofibromatosis 2 : a twenty first century perspective. Lancet Neurol, 2007, 6 : 340-351.
  • 6Baser ME, Friedman JM, Wallace A J, et al. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology, 2002, 59 : 1759-1765.
  • 7Parry DM, Eldridge R, Kaiser-Kupfer MI, et al. Neurofibromatosis 2 ( NF2 ) : clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet, 1994, 52 : 450- 461.
  • 8Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med, 1992, 84: 603-618.
  • 9Sener RN, Dzelzite S, Migals A, et al. Prominent myelin vacuolization in neurofibromatosis type 2. Clin Imaging, 2003, 27 : 11-13.
  • 10Samii M, Gerganov V,Samii A. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results. Prog Neurnl Surg, 2008,21:169-175.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部